A systematic review of the effectiveness of policies restricting access to pregabalin - Stacey BR, Liss J, Behar R, Sadosky A, Parsons B, Masters ET, Hlavacek P.

BACKGROUND: Formularies often employ restriction policies to reduce pharmacy costs. Pregabalin, an alpha-2-delta ligand, is approved for treatment of fibromyalgia (FM); neuropathic pain (NeP) due to postherpetic neuralgia (PHN), diabetic peripheral neuropa...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news